MARK VIETH

H.R. 8774/S.4921, FY25 Defense Appropriations Act, DoD research on congenital CMV

H.R. 8774/S.4921, FY25 Defense Appropriations Act, DoD research on congenital CMV; H.R. 9029/S. 4924, FY25 Labor-Health and Human Services-Education Act, NIH research on CMV and CDC and HRSA support for CMV testing and surveillance

H.R. 8774/S.4921, FY25 Defense Appropriations Act, DoD research on congenital CMV; H.R. 9029/S.4924, FY25 Labor-Health and Human Services-Education Act, NIH research on CMV and CDC and HRSA support for CMV testing and surveillance; H.R. 7542/S. 3757, Stop CMV Act

H.R. 8774/S.4921, FY25 Defense Appropriation, DoD research on Von Hippel-Lindau syndrome

H.R. 8774/S.4921, FY25 Defense Appropriation, DoD research on Von Hippel-Lindau syndrome; H.R. 9029/S.4924, FY25 Labor-Health and Human Services-Education Act, NIH research on Von Hippel-Lindau syndrome

H.R. 9029/S.4942, FY25 Labor-Health and Human Services-Education Act, kidney cancer research at NIH

FOUNDATION FOR PERIPHERAL NEUROPATHY

PANCREATIC CANCER ACTION NETWORK (PANCAN)

NATIONAL CMV FOUNDATION

KIDNEYCAN

VHL ALLIANCE

TUBEROUS SCLEROSIS ALLIANCE

RHOADS INDUSTRIES

THE MANN CENTER FOR THE PERFORMING ARTS

DEFENSE HEALTH RESEARCH CONSORTIUM

THE MANN CENTER FOR THE PERFORMING ARTS

HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION

HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION